Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction

Area of Science:

• Neurology
• Pain Management
• Regenerative Medicine

Background:

• Complex Regional Pain Syndrome (CRPS) type II presents severe allodynia post-trauma.
• Surgical debridement and flap reconstruction were performed for post-traumatic necrosis.
• Conventional treatments like NSAIDs show limited efficacy for CRPS pain.

Discussion:

• Subcutaneous Botulinum toxin type A (BTX-A) demonstrated rapid pain relief in a CRPS type II patient.
• BTX-A offers a promising alternative to conventional pain management strategies.
• The study highlights the potential of BTX-A in managing severe neuropathic pain.

Key Insights:

• Subcutaneous BTX-A effectively alleviated severe allodynia in CRPS type II.
• The treatment improved daily life functioning for the patient.
• Rapid pain reduction was observed following BTX-A administration.

Outlook:

• Further clinical research is warranted to validate subcutaneous BTX-A efficacy in CRPS type II.
• Development of safe and standardized outpatient protocols for BTX-A treatment is recommended.
• Exploring BTX-A's role in managing other neuropathic pain conditions is a future direction.